Eyepoint Pharmaceuticals (EYPT) Stock Price
$6.15 3.1%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
1 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Eyepoint Pharmaceuticals, AI stock picks, stock alerts and much more.
EYPT AI Stock Analysis
AI stock analysis for EYPT is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Eyepoint Pharmaceuticals (EYPT) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Eyepoint Pharmaceuticals (EYPT) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Eyepoint Pharmaceuticals (EYPT), currently trading at $6.15, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About EYPT
-
EyePoint Pharmaceuticals, Inc.
-
Symbol
EYPT
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
419.7M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
EYPT Alternative Data
Web Traffic
Eyepoint Pharmaceuticals receives an estimated 6397 monthly visitors to eyepointpharma.com.
-
Web Traffic
6397
-
Change from Previous Month
2.6%
-
3 Month Change
21.6%
-
YoY Change
21.6%
Reddit Mentions
Eyepoint Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
News Mentions
Eyepoint Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Facebook Engagement
Eyepoint Pharmaceuticals has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Followers
14,160 are following Eyepoint Pharmaceuticals on LinkedIn, up by 2.8% over the last month.
-
LinkedIn Followers
14160
-
Daily Change
0.1%
-
1 Month Change
2.8%
-
3 Month Change
7%
Job Postings
Eyepoint Pharmaceuticals has an estimated 8 open job postings, which is down -50% over the last month.
-
Job Postings
8
-
Daily Change
11.1%
-
1 Month Change
50%
-
3 Month Change
27.3%
-
YoY Change
27.3%
LinkedIn Employees
According to LinkedIn, Eyepoint Pharmaceuticals has 194 employees, down by -0.5% over the last month.
-
LinkedIn Employees
194
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
7.8%
-
YoY Change
7.8%
Twitter Followers
Eyepoint Pharmaceuticals has 1,420 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
1420
-
Daily Change
0.1%
-
1 Month Change
0.1%
-
3 Month Change
6.9%
-
YoY Change
6.9%
Business Outlook
-
Business Outlook
44
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
EYPT Financials
EYPT Key Metrics
-
Total Revenue
$10.5M
-
Net Income
-$29.4M
-
Earnings per Share
-$0.54
-
Free cash flow
-$40.6M
-
EBITDA
-$29M
-
EBITDA Ratio
-2.75114
-
Total Assets
$300.9M
EYPT 2-year Revenue & Income
EYPT 2-year Free Cash Flow
EYPT Technicals
EYPT SMA
EYPT RSI
FAQ
What's the current price of Eyepoint Pharmaceuticals (EYPT) Stock?
The price of an Eyepoint Pharmaceuticals (EYPT) share is $6.15.
What's the market cap of Eyepoint Pharmaceuticals?
The current market cap of Eyepoint Pharmaceuticals is 419.7M.
Should I buy or sell EYPT?
Eyepoint Pharmaceuticals shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Eyepoint Pharmaceuticals is better viewed as a hold or accumulate position while waiting for further developments.
Is Eyepoint Pharmaceuticals a good investment?
The current analysis of Eyepoint Pharmaceuticals' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Eyepoint Pharmaceuticals' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Eyepoint Pharmaceuticals (EYPT) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Eyepoint Pharmaceuticals stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Eyepoint Pharmaceuticals (EYPT) that investors often compare it to?
Eyepoint Pharmaceuticals (EYPT) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Eyepoint Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Eyepoint Pharmaceuticals' stock price to be around $5.81 in 2026. Starting from the current price of $6.15, this represents a 5.5% change in price, indicating a bearish outlook for the stock.
How to buy Eyepoint Pharmaceuticals (EYPT) Stock?
Eyepoint Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Eyepoint Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.